Orthogonal ensemble and single-particle characterisation of antisense oligonucleotide lipid nanoparticles
RSC Pharmaceutics · 2026
DOI: 10.1039/d6pm00312e ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Callum G Davidson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde 161 Cathedral St. Glasgow G4 0RE Scotland UK zahra.rattray@strat…. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
A stepwise optimisation strategy for ASO-loaded LNPs integrating microfluidic LNP manufacture with high-resolution CQA analysis, enables data-driven formulation refinement, and accelerates LNP design.
Autor:innen und Institutionen
- Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde 161 Cathedral St. Glasgow G4 0RE Scotland UK zahra.rattray@strath.ac.uk.
- School of Molecular Biosciences, University of Glasgow Glasgow G11 6EW UK.
ORCID-Profile: Callum G Davidson, Savvas Ioannou, Yvonne Perrie, Zahra Rattray
Förderung
- Engineering and Physical Sciences Research Council
Zitieren
APA
Davidson, C. G., Rae, P., Ioannou, S., Perrie, Y., & Rattray, Z. (2026). Orthogonal ensemble and single-particle characterisation of antisense oligonucleotide lipid nanoparticles. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00312e
Vancouver
Davidson CG, Rae P, Ioannou S, Perrie Y, Rattray Z. Orthogonal ensemble and single-particle characterisation of antisense oligonucleotide lipid nanoparticles. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00312e
BibTeX
@article{Davidson2026,
author = {Davidson, Callum G and Rae, Pascale and Ioannou, Savvas and Perrie, Yvonne and Rattray, Zahra},
title = {Orthogonal ensemble and single-particle characterisation of antisense oligonucleotide lipid nanoparticles},
journal = {RSC Pharmaceutics},
year = {2026},
doi = {10.1039/d6pm00312e}
}
EUVIMED